Denovo Biopharma Forms Neuroscience Advisory Board for Depression
06 Jun 2025 //
GLOBENEWSWIRE
FDA Grants Fast Track Designation For Biomarker-Guided DB104
09 Oct 2024 //
PR NEWSWIRE
Denovo Biopharma: Positive Phase 2b Depression Data For DB104 At ASCP
28 May 2024 //
PR NEWSWIRE